Loading company…
Gaithersburg-based pharmaceutical company developing treatments for rare metabolic disorders.
Vtesse, Inc. is headquartered in Gaithersburg, US, and develops and commercializes treatments for rare metabolic disorders, selling through partnerships and direct sales to healthcare providers. The company was acquired by Sucampo Pharmaceuticals, Inc. on April 3, 2017, for USD 200 mn from several venture-backed investors. Its stage is recorded as Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in